Par Drugs and Chemicals (NSE:PAR) EV-to-Revenue : 2.61 (As of May. 30, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Par Drugs and Chemicals's enterprise value is ₹2,498.0 Mil. Par Drugs and Chemicals's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹956.4 Mil. Therefore, Par Drugs and Chemicals's EV-to-Revenue for today is 2.61.

The historical rank and industry rank for Par Drugs and Chemicals's EV-to-Revenue or its related term are showing as below:

NSE:PAR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.57 Med: 2.53 Max: 4.93
Current: 2.61

During the past 8 years, the highest EV-to-Revenue of Par Drugs and Chemicals was 4.93. The lowest was 1.57. And the median was 2.53.

NSE:PAR's EV-to-Revenue is ranked worse than
54.99% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs NSE:PAR: 2.61

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Par Drugs and Chemicals's stock price is ₹232.80. Par Drugs and Chemicals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹77.72. Therefore, Par Drugs and Chemicals's PS Ratio for today is 3.00.

Par Drugs and Chemicals EV-to-Revenue Historical Data

The historical data trend for Par Drugs and Chemicals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals EV-to-Revenue Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

0.33

1.06

2.43

1.57

2.39

Par Drugs and Chemicals Quarterly Data
	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.57	2.73	2.39	2.73	2.39

Competitive Comparison of Par Drugs and Chemicals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Par Drugs and Chemicals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's EV-to-Revenue falls into.

Par Drugs and Chemicals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Par Drugs and Chemicals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2497.980	/	956.403
	=	2.61

Par Drugs and Chemicals's current Enterprise Value is ₹2,498.0 Mil.
Par Drugs and Chemicals's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹956.4 Mil.

Par Drugs and Chemicals (NSE:PAR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Par Drugs and Chemicals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	232.80	/	77.716
	=	3.00

Par Drugs and Chemicals's share price for today is ₹232.80.
Par Drugs and Chemicals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹77.72.

Par Drugs and Chemicals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Par Drugs and Chemicals (NSE:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website

https://www.pardrugs.com

Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage.